Feasibility of Using NeuraSignal Transcranial Doppler Robot
ConditionCerebral Autoregulation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorUniversity of Alabama at Birmingham
About this trial
The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
Eligibility criteria
Qualifiers
18-89
Patients admitted to the Neuro ICU for blood pressure management (MAP management) after spinal surgery
Disqualifiers
Patients under 18 years (or bodyweight <50kg if age unknown),
prisoners
pregnant women,
non-English speaking,
Trial design
Treatments tested in this trial
- NeuraSignal transcranial doppler robot
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov